My professional life is dedicated to researching the public policy implications of various emerging technologies. Of the many issues and sectors that I cover, none are more interesting or important than advanced medical innovation. After all, new health care technologies offer the greatest hope for improving human welfare and longevity. Consequently, the public policies that govern these technologies and sectors will have an important bearing on just how much life-enriching or life-saving medical innovation we actually get going forward.
Few people are doing better reporting on the intersection of advanced technology and medicine — as well as the effects of regulation on those fields — than my Mercatus Center colleague Jordan Reimschisel. In a very short period of time, Jordan has completely immersed himself in these complex, cutting-edge topics and produced a remarkable body of work discussing how, in his words, “technology can merge with medicine to democratize medical decision making, empower patients to participate in the treatment process, and promote better health outcomes for more patients at lower and lower costs.” He gets deep into the weeds of the various technologies he writes about as well as the legal, ethical, and economic issues surrounding each topic.
I encouraged him to start an ongoing compendium of his work on these topics so that we could continue to highlight his research, some of which I have been honored to co-author with him. I have listed his current catalog down below, but jump over to this Medium page he set up and bookmark it for future reference. This is some truly outstanding work and I am excited to see where he goes next with topics as wide-ranging as “biohackerspaces,” democratized or “personalized” medicine, advanced genetic testing and editing techniques, and the future of the FDA in an age of rapid change.
Give Jordan a follow on Twitter (@jtreimschisel) and make sure to follow his Medium page for his dispatches from the front lines of the debate over advanced medical innovation and its regulation.
Artificial Intelligence
“Artificial Intelligence Advances”
“That AI You Hate, You Really Love” Co-written with Adam Thierer
Biohackerspaces
Food and Drug Administration
“FDA Needs a Fresh Approach, and Fast” Co-written with Adam Thierer
“Insurance costs just the tip of the iceberg. Time to reform the FDA.” Co-written with Dr. Robert Graboyes
“Opening the Door for Medical Innovation” Co-written with Dr. Robert Graboyes
“The True Goal of the FDA Should Be Drug Innovation”
“Toward Patient-Centered Policy”
“When it comes to tobacco and cigarettes, people are smarter than you think”
Genetics
“Will Genetic Editing Advance Faster Than Our Ability to Regulate It?” Co-written with Adam Thierer
Personalized Medicine
“The Creative Destruction of Medicine: A Book Review”
“Technology Could Enable Personal Medicine Whether We Like It Or Not”